Drug intelligence / Profile preview

desoxycorticosterone pivalate

Development stage
Unknown
Lead developer
Dechra Veterinary Products
Modality
Small Molecules
Administration
Intramuscular, Subcutaneous
01

Overview

Desoxycorticosterone pivalate is a long-acting synthetic mineralocorticoid hormone and an analog of desoxycorticosterone. It is primarily used as a replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison’s disease). The drug mimics the effects of endogenous aldosterone by increasing sodium retention and promoting potassium excretion in the kidneys. Mechanistically, it acts as an agonist at the mineralocorticoid receptor; after binding to this receptor, it forms a steroid-receptor complex that translocates to the nucleus and induces transcription of specific proteins responsible for electrolyte balance. Desoxycorticosterone pivalate has little or no glucocorticoid activity and should be used alongside appropriate glucocorticoid therapy when treating Addison’s disease[1][2][4][5][6].

Brand names
Percorten-VZycortal
Other names
desoxycorticosterone pivalate21-(2,2-dimethyl-1-oxopropoxy)-pregn-4-ene-3,20-dione
02

Targets

MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on desoxycorticosterone pivalate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on desoxycorticosterone pivalate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call